James J Schutz Form 4 Sonoma Pharmaceuticals / James J Schutz ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Schutz James J

(Last) (First) (Middle)

C/O SONOMA PHARMACEUTICALS, INC.

1129 N. MCDOWELL BLVD.

(Street)

PETALUMA CA 94954

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sonoma Pharmaceuticals, Inc. [ SNOA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
Former CEO and Former Director

3. Date of Earliest Transaction (Month/Day/Year)
01/14/2019

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								35,858	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	$38.15	01/14/2019		H			5,271	(1)	01/14/2019	Common Stock	5,271	(2)	188,087	D
Stock option (right to buy)	$66.85	01/14/2019		H			3,571	(1)	01/14/2019	Common Stock	3,571	(3)	184,516	D
Stock option (right to buy)	$68.95	01/14/2019		H			1,785	(1)	01/14/2019	Common Stock	1,785	(4)	182,731	D
Stock option (right to buy)	$70.35	01/14/2019		H			3,928	(1)	01/14/2019	Common Stock	3,928	(5)	178,803	D
Stock option (right to buy)	$56	01/14/2019		H			1,428	(1)	01/14/2019	Common Stock	1,428	(6)	177,375	D
Stock option (right to buy)	$43.75	01/14/2019		H			5,357	(1)	01/14/2019	Common Stock	5,357	(7)	172,018	D
Stock option (right to buy)	$32.55	01/14/2019		H			4,285	(1)	01/14/2019	Common Stock	4,285	(8)	167,733	D
Stock option (right to buy)	$30	01/14/2019		H			20,000	(1)	01/14/2019	Common Stock	20,000	(9)	147,733	D
Stock option (right to buy)	$4.81	01/14/2019		H			50,000	(1)	01/14/2019	Common Stock	50,000	(10)	97,733	D
Stock option (right to buy)	$7.06	01/14/2019		H			30,000	(1)	01/14/2019	Common Stock	30,000	(11)	67,733	D
Stock option (right to buy)	$2.41	01/14/2019		H			67,733	(1)	01/14/2019	Common Stock	67,733	(12)	0	D

Explanation of Responses:

1. The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Schutz, dated December 13, 2018.

2. The stock options were originally granted on March 10, 2009.

3. The stock options were originally granted on February 10, 2010.

4. The stock options were originally granted on June 7, 2010 pursuant to the Issuer's 2010 Bonus Plan.

5. The stock options were originally granted on March 31, 2011 pursuant to the Issuer's 2010 Bonus Plan in lieu of cash.

6. The stock options were originally granted on June 16, 2011 pursuant to the Issuer's 2011 Bonus Plan in lieu of cash.

7. The stock options were originally granted on March 7, 2012 pursuant to the Issuer's 2011 Bonus Plan.

8. The stock options were originally granted on August 24, 2012 pursuant to the Issuer's 2012 Bonus Plan in lieu of cash.

9. The stock options were originally granted on September 19, 2013 pursuant to the Issuer's entry into a new employment agreement with him, effective June 02, 2013.

10. The stock options were originally granted on November 30, 2016 as a signing bonus for his employment agreement, dated July 26, 2016.

11. The stock options were originally granted on April 3, 2017 in connection with his services as the Issuer's CEO.

12. The stock options were originally granted on July 20, 2018 as a bonus for fiscal year 2018.

	/s/ Jim Schutz	01/15/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.